Vertex Pharmaceuticals Incorporated announced that effective January 20, 2015, Kenneth L. Horton transitioned from his role as the executive vice president and chief legal officer to a role as special counsel to chief executive officer. In his new role, Horton is no longer an executive officer of the company.